T. van der Horst

785 citations
9 papers · 543 indexed · 1 hit paper · h-index 6
Topics
HER2/EGFR in Cancer Research (4 papers)Service and Product Innovation (2 papers)Mosquito-borne diseases and control (2 papers)

In The Last Decade

T. van der Horst

8 papers receiving 532 citations

Hit Papers

Trastuzumab emtansine versus taxane use for previously tr...20172026202020232017100200300

Peers

T. van der Horst
Comparison fields: 5 of 61
  • Oncology 344
  • Pulmonary and Respiratory Medicine 310
  • Radiology, Nuclear Medicine and Imaging 133
  • Surgery 106
  • Gastroenterology 100
Replace Chaoran Ji with:
Chaoran Ji China
Betsy Althaus United States
Markus Möhler Germany
Hema Mahajan Australia
Yusuke Makiguchi Japan
Matthew E. Witek United States
Jean S. Wang United States
Steven B. Maron United States
Sanjeev Gill Australia
T. van der Horst relative to Chaoran Ji China Chaoran Ji's profile →
Citations per field
00.5×10×15.7×
Chaoran Ji · 1×
Citations per year

Countries citing papers authored by T. van der Horst

Since Specialization
Citations

This map shows the geographic impact of T. van der Horst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. van der Horst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. van der Horst more than expected).

Fields of papers citing papers by T. van der Horst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. van der Horst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. van der Horst. The network helps show where T. van der Horst may publish in the future.

Co-authorship network of co-authors of T. van der Horst

This figure shows the co-authorship network connecting the top 25 collaborators of T. van der Horst. A scholar is included among the top collaborators of T. van der Horst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. van der Horst. T. van der Horst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 28
2 16
3
Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 studybreakdown →
391
4 58
5 8
6 3
7 0
8 36
9 3

About T. van der Horst

T. van der Horst is a scholar working on Marketing, Endocrinology and Oncology, having authored 9 papers that have together received 543 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Service and Product Innovation (2 papers) and Mosquito-borne diseases and control (2 papers). The work is most often cited by research in Gastroenterology (100 citations), Oncology (344 citations) and Pulmonary and Respiratory Medicine (310 citations). T. van der Horst has collaborated with scholars based in Switzerland, United States and Japan. Frequent co-authors include Peter Thuss‐Patience, Betsy Althaus, Manish A. Shah, Eric Van Cutsem, Yoon‐Koo Kang, Atsushi Ohtsu, Jaffer A. Ajani, Hyun Cheol Chung, Wasat Mansoor and Gail D. Lewis Phillips. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026